T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
1301
DELISTED
Masimo
MASI
| $14.5M | ﹤0.01% |
99,706
+71,521
| +254% | +$13.7M |
|
1302
NRG Energy
NRG
$25.4B
| $14.5M | ﹤0.01% |
377,625
+13,913
| +4% | +$542K |
|
|
RDUS
1303
DELISTED
Radius Health, Inc.
RDUS
| $14.4M | ﹤0.01% |
1,631,498
+37,451
| +2% | +$284K |
|
|
GTM
1304
ZoomInfo Technologies
GTM
$1.25B
| $14.3M | ﹤0.01% |
240,018
+27,318
| +13% | +$1.47M |
|
1305
ePlus
PLUS
$2.32B
| $14.3M | ﹤0.01% |
254,424
+2,496
| +1% | +$124K |
|
|
SPLK
1306
DELISTED
Splunk Inc
SPLK
| $14.1M | ﹤0.01% |
95,200
-3,946,125
| -98% | -$483M |
|
1307
BorgWarner
BWA
$14B
| $14.1M | ﹤0.01% |
411,886
-17,953
| -4% | -$671K |
|
|
ACCD
1308
DELISTED
Accolade Inc
ACCD
| $14.1M | ﹤0.01% |
802,456
+2,756
| +0.3% | +$50.7K |
|
|
MANT
1309
DELISTED
Mantech International Corp
MANT
| $14.1M | ﹤0.01% |
163,128
+25,892
| +19% | +$2.07M |
|
1310
BlackLine
BL
$1.82B
| $14M | ﹤0.01% |
190,546
+6,773
| +4% | +$548K |
|
|
FOLD
1311
DELISTED
Amicus Therapeutics
FOLD
| $13.8M | ﹤0.01% |
1,461,131
-604,011
| -29% | -$5.66M |
|
1312
Globe Life
GL
$13.8B
| $13.8M | ﹤0.01% |
137,145
-11,758
| -8% | -$1.19M |
|
1313
Enanta Pharmaceuticals
ENTA
$393M
| $13.7M | ﹤0.01% |
193,059
-81,258
| -30% | -$5.29M |
|
1314
Molson Coors Class B
TAP
$7.75B
| $13.7M | ﹤0.01% |
255,819
-19,446
| -7% | -$980K |
|
1315
Thryv Holdings
THRY
$96.9M
| $13.5M | ﹤0.01% |
481,716
-235,187
| -33% | -$7.38M |
|
1316
Pinnacle West Capital
PNW
$12.2B
| $13.4M | ﹤0.01% |
172,054
-15,780
| -8% | -$1.13M |
|
|
CDR
1317
DELISTED
Cedar Realty Trust, Inc
CDR
| $13.4M | ﹤0.01% |
485,771
-1,689,218
| -78% | -$42.4M |
|
1318
The Bancorp
TBBK
$2.83B
| $13.3M | ﹤0.01% |
467,954
+448,272
| +2,278% | +$12.9M |
|
1319
Definitive Healthcare
DH
$69.4M
| $13.2M | ﹤0.01% |
533,818
-762,087
| -59% | -$17.2M |
|
|
PRDS
1320
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $13.1M | ﹤0.01% |
1,816,559
-1,395,916
| -43% | -$13.7M |
|
|
ICVX
1321
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $12.9M | ﹤0.01% |
1,835,857
+237,305
| +15% | +$3.73M |
|
|
EXAI
1322
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $12.9M | ﹤0.01% |
895,976
+14,898
| +2% | +$254K |
|
|
NSTG
1323
DELISTED
NanoString Technologies, Inc.
NSTG
| $12.9M | ﹤0.01% |
371,056
+356,155
| +2,390% | +$12.3M |
|
1324
Norwegian Cruise Line
NCLH
$8.98B
| $12.8M | ﹤0.01% |
586,394
+36,378
| +7% | +$743K |
|
1325
Applovin
APP
$105B
| $12.8M | ﹤0.01% |
231,919
-30,244
| -12% | -$1.92M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.